Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]

Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2020-02, Vol.294, p.16-16
Hauptverfasser: Pottle, Alison, Thompson, Gilbert, Barbir, Mahmoud, Bayly, Graham, Cegla, Jaimini, Cramb, Robert, Dawson, Tina, Eatough, Ruth, Kale, Vaishali, Neuwirth, Clare, Nicholson, Kirsty, Payne, Jules, Scott, James, Soran, Handrean, Walji, Shahenaz, Watkins, Suzanne, Weedon, Hazel, Datta, Dev Borunendra Nath
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16
container_issue
container_start_page 16
container_title Atherosclerosis
container_volume 294
creator Pottle, Alison
Thompson, Gilbert
Barbir, Mahmoud
Bayly, Graham
Cegla, Jaimini
Cramb, Robert
Dawson, Tina
Eatough, Ruth
Kale, Vaishali
Neuwirth, Clare
Nicholson, Kirsty
Payne, Jules
Scott, James
Soran, Handrean
Walji, Shahenaz
Watkins, Suzanne
Weedon, Hazel
Datta, Dev Borunendra Nath
description
doi_str_mv 10.1016/j.atherosclerosis.2019.12.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2339004439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915019316338</els_id><sourcerecordid>2339004439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2345-d0aa9e407e1cd59738e61489745a1baa7a827d9785d420fbed4cd3c06eeaf3eb3</originalsourceid><addsrcrecordid>eNqNUU2O0zAUthCIKQNXQN4gDRIJduw0MRKLqmIGRAUSYlYIWY790rpK4mAnlbrrHWYLF-IYPQmOOoyAFZvnxft-_L0PoWeUpJTQ-cttqoYNeBd0M00b0oxQkdIsJTS_h2a0LERCecnvoxkhGU0EzckZehTClhDCC1o-RGeMCpbPWT5DP5fOe7uGzowtHhw-Hr6vbO967wawHVZ99ILogqGurVZ6_wLrjWoa6NYQsOoMduOgXQvhFV5gA0F72w92B3Gnmv3ErL2L0hvA1-_xn9qLO-1PsLZh8FGbilIcDzcxUnE8_MBfFn9nxZkg-OKD20FbgcdT8ueY88jI6dfH6EGtmgBPbt9zdH355vPybbL6ePVuuVglOmM8TwxRSgAnBVBtclGwEubxXqLguaKVUoUqs8KIoswNz0hdgeHaME3mAKpmULFzdHHSjUG-jRAG2dqgoWlUB24MMmNMxEtzJiL09Qmq4_eDh1r23rbK7yUlcqpTbuU_dcoplKSZjHVG_tNbq7Fqwdyxf_cXAVcnAMTAOwteBm2h02CsBz1I4-x_Wv0C2AXAkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2339004439</pqid></control><display><type>article</type><title>Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]</title><source>Access via ScienceDirect (Elsevier)</source><creator>Pottle, Alison ; Thompson, Gilbert ; Barbir, Mahmoud ; Bayly, Graham ; Cegla, Jaimini ; Cramb, Robert ; Dawson, Tina ; Eatough, Ruth ; Kale, Vaishali ; Neuwirth, Clare ; Nicholson, Kirsty ; Payne, Jules ; Scott, James ; Soran, Handrean ; Walji, Shahenaz ; Watkins, Suzanne ; Weedon, Hazel ; Datta, Dev Borunendra Nath</creator><creatorcontrib>Pottle, Alison ; Thompson, Gilbert ; Barbir, Mahmoud ; Bayly, Graham ; Cegla, Jaimini ; Cramb, Robert ; Dawson, Tina ; Eatough, Ruth ; Kale, Vaishali ; Neuwirth, Clare ; Nicholson, Kirsty ; Payne, Jules ; Scott, James ; Soran, Handrean ; Walji, Shahenaz ; Watkins, Suzanne ; Weedon, Hazel ; Datta, Dev Borunendra Nath</creatorcontrib><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2019.12.015</identifier><identifier>PMID: 31935635</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><ispartof>Atherosclerosis, 2020-02, Vol.294, p.16-16</ispartof><rights>2019 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2345-d0aa9e407e1cd59738e61489745a1baa7a827d9785d420fbed4cd3c06eeaf3eb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.atherosclerosis.2019.12.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31935635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pottle, Alison</creatorcontrib><creatorcontrib>Thompson, Gilbert</creatorcontrib><creatorcontrib>Barbir, Mahmoud</creatorcontrib><creatorcontrib>Bayly, Graham</creatorcontrib><creatorcontrib>Cegla, Jaimini</creatorcontrib><creatorcontrib>Cramb, Robert</creatorcontrib><creatorcontrib>Dawson, Tina</creatorcontrib><creatorcontrib>Eatough, Ruth</creatorcontrib><creatorcontrib>Kale, Vaishali</creatorcontrib><creatorcontrib>Neuwirth, Clare</creatorcontrib><creatorcontrib>Nicholson, Kirsty</creatorcontrib><creatorcontrib>Payne, Jules</creatorcontrib><creatorcontrib>Scott, James</creatorcontrib><creatorcontrib>Soran, Handrean</creatorcontrib><creatorcontrib>Walji, Shahenaz</creatorcontrib><creatorcontrib>Watkins, Suzanne</creatorcontrib><creatorcontrib>Weedon, Hazel</creatorcontrib><creatorcontrib>Datta, Dev Borunendra Nath</creatorcontrib><title>Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNUU2O0zAUthCIKQNXQN4gDRIJduw0MRKLqmIGRAUSYlYIWY790rpK4mAnlbrrHWYLF-IYPQmOOoyAFZvnxft-_L0PoWeUpJTQ-cttqoYNeBd0M00b0oxQkdIsJTS_h2a0LERCecnvoxkhGU0EzckZehTClhDCC1o-RGeMCpbPWT5DP5fOe7uGzowtHhw-Hr6vbO967wawHVZ99ILogqGurVZ6_wLrjWoa6NYQsOoMduOgXQvhFV5gA0F72w92B3Gnmv3ErL2L0hvA1-_xn9qLO-1PsLZh8FGbilIcDzcxUnE8_MBfFn9nxZkg-OKD20FbgcdT8ueY88jI6dfH6EGtmgBPbt9zdH355vPybbL6ePVuuVglOmM8TwxRSgAnBVBtclGwEubxXqLguaKVUoUqs8KIoswNz0hdgeHaME3mAKpmULFzdHHSjUG-jRAG2dqgoWlUB24MMmNMxEtzJiL09Qmq4_eDh1r23rbK7yUlcqpTbuU_dcoplKSZjHVG_tNbq7Fqwdyxf_cXAVcnAMTAOwteBm2h02CsBz1I4-x_Wv0C2AXAkA</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Pottle, Alison</creator><creator>Thompson, Gilbert</creator><creator>Barbir, Mahmoud</creator><creator>Bayly, Graham</creator><creator>Cegla, Jaimini</creator><creator>Cramb, Robert</creator><creator>Dawson, Tina</creator><creator>Eatough, Ruth</creator><creator>Kale, Vaishali</creator><creator>Neuwirth, Clare</creator><creator>Nicholson, Kirsty</creator><creator>Payne, Jules</creator><creator>Scott, James</creator><creator>Soran, Handrean</creator><creator>Walji, Shahenaz</creator><creator>Watkins, Suzanne</creator><creator>Weedon, Hazel</creator><creator>Datta, Dev Borunendra Nath</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202002</creationdate><title>Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]</title><author>Pottle, Alison ; Thompson, Gilbert ; Barbir, Mahmoud ; Bayly, Graham ; Cegla, Jaimini ; Cramb, Robert ; Dawson, Tina ; Eatough, Ruth ; Kale, Vaishali ; Neuwirth, Clare ; Nicholson, Kirsty ; Payne, Jules ; Scott, James ; Soran, Handrean ; Walji, Shahenaz ; Watkins, Suzanne ; Weedon, Hazel ; Datta, Dev Borunendra Nath</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2345-d0aa9e407e1cd59738e61489745a1baa7a827d9785d420fbed4cd3c06eeaf3eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pottle, Alison</creatorcontrib><creatorcontrib>Thompson, Gilbert</creatorcontrib><creatorcontrib>Barbir, Mahmoud</creatorcontrib><creatorcontrib>Bayly, Graham</creatorcontrib><creatorcontrib>Cegla, Jaimini</creatorcontrib><creatorcontrib>Cramb, Robert</creatorcontrib><creatorcontrib>Dawson, Tina</creatorcontrib><creatorcontrib>Eatough, Ruth</creatorcontrib><creatorcontrib>Kale, Vaishali</creatorcontrib><creatorcontrib>Neuwirth, Clare</creatorcontrib><creatorcontrib>Nicholson, Kirsty</creatorcontrib><creatorcontrib>Payne, Jules</creatorcontrib><creatorcontrib>Scott, James</creatorcontrib><creatorcontrib>Soran, Handrean</creatorcontrib><creatorcontrib>Walji, Shahenaz</creatorcontrib><creatorcontrib>Watkins, Suzanne</creatorcontrib><creatorcontrib>Weedon, Hazel</creatorcontrib><creatorcontrib>Datta, Dev Borunendra Nath</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pottle, Alison</au><au>Thompson, Gilbert</au><au>Barbir, Mahmoud</au><au>Bayly, Graham</au><au>Cegla, Jaimini</au><au>Cramb, Robert</au><au>Dawson, Tina</au><au>Eatough, Ruth</au><au>Kale, Vaishali</au><au>Neuwirth, Clare</au><au>Nicholson, Kirsty</au><au>Payne, Jules</au><au>Scott, James</au><au>Soran, Handrean</au><au>Walji, Shahenaz</au><au>Watkins, Suzanne</au><au>Weedon, Hazel</au><au>Datta, Dev Borunendra Nath</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2020-02</date><risdate>2020</risdate><volume>294</volume><spage>16</spage><epage>16</epage><pages>16-16</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31935635</pmid><doi>10.1016/j.atherosclerosis.2019.12.015</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2020-02, Vol.294, p.16-16
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_2339004439
source Access via ScienceDirect (Elsevier)
title Corrigendum to “Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017” [Atherosclerosis 290 (November 2019) 44–51]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A03%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CLipoprotein%20apheresis%20efficacy,%20challenges%20and%20outcomes:%20A%20descriptive%20analysis%20from%20the%20UK%20Lipoprotein%20Apheresis%20Registry,%201989%E2%80%932017%E2%80%9D%20%5BAtherosclerosis%20290%20(November%202019)%2044%E2%80%9351%5D&rft.jtitle=Atherosclerosis&rft.au=Pottle,%20Alison&rft.date=2020-02&rft.volume=294&rft.spage=16&rft.epage=16&rft.pages=16-16&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2019.12.015&rft_dat=%3Cproquest_cross%3E2339004439%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2339004439&rft_id=info:pmid/31935635&rft_els_id=S0021915019316338&rfr_iscdi=true